---
title: "OWLET INC | 8-K: FY2025 Q2 Revenue: USD 26.1 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252101545.md"
datetime: "2025-08-07T20:26:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252101545.md)
  - [en](https://longbridge.com/en/news/252101545.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252101545.md)
generator: "portal-rs"
---

# OWLET INC | 8-K: FY2025 Q2 Revenue: USD 26.1 M

Revenue: As of FY2025 Q2, the actual value is USD 26.1 M.

EPS: As of FY2025 Q2, the actual value is USD -2.37.

EBIT: As of FY2025 Q2, the actual value is USD -36.5 M.

### Segment Revenue

-   Q2 2025 Revenue: $26.1 million, an increase of 25.9% from Q2 2024, primarily due to higher sales of Dream Sock and Dream Duo products.

### Operational Metrics

-   Q2 2025 Gross Margin: 51.3%, up 180 basis points from Q2 2024.
-   Q2 2025 Net Loss: $37.6 million, including a $34.8 million non-cash, mark-to-market common stock warrant liability adjustment, compared to a net loss of $1.1 million in Q2 2024.
-   Q2 2025 Adjusted EBITDA: $0.3 million, an improvement of $0.2 million compared to Q2 2024.
-   Operating Loss: $1.9 million for Q2 2025, compared to $2.2 million for Q2 2024.

### Cash Flow

-   Net cash used in operating activities for the six months ended June 30, 2025: - $8.2 million, compared to - $6.7 million for the same period in 2024.

### Unique Metrics

-   Owlet360 subscription surpassed 66,000 paying subscribers, with growth in monthly recurring revenue, attach rate, retention rate, and consumer satisfaction.

### Outlook / Guidance

-   For the full year 2025, Owlet expects revenue in the range of $97 million to $100 million, representing 24% to 28% growth year-over-year. Gross margins are anticipated to be between 46% and 50%, including the impact of new expected tariff costs. The company fully expects to be adjusted EBITDA profitable for the full year 2025.

### Related Stocks

- [OWLTW.US](https://longbridge.com/en/quote/OWLTW.US.md)

## Related News & Research

- [Is Camtek (CAMT) Options Frenzy Quietly Reframing Its Near‑Term Earnings Story?](https://longbridge.com/en/news/298114664.md)
- [The Bull Case For Natera (NTRA) Could Change Following New Signatera Lymphoma Data And Komen Partnership](https://longbridge.com/en/news/298111249.md)
- [Stronger Q2 Results And Raised 2026 Outlook Could Be A Game Changer For IDEXX Laboratories (IDXX)](https://longbridge.com/en/news/298111178.md)
- [NBH Bank Makes New Investment in Bank of America Corporation $BAC](https://longbridge.com/en/news/298108822.md)
- [MW Advisory LLC Makes New $1.77 Million Investment in Visa Inc. $V](https://longbridge.com/en/news/298108585.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**